What Researchers Did
Researchers conducted a randomised controlled trial to compare the effects of lipoic acid (LA) or its R-(+)-lipoic acid (RLA) enantiomer, both supplemented to hyperbaric oxygen therapy (HBOT), on chronic leg wound healing.
What They Found
Ulcers improved more significantly in the RLA group compared to the LA and placebo groups. Both LA and RLA groups demonstrated increased EGF and VEGF levels over time, while RLA uniquely decreased IL-6 on days 7 and 14, and TNF-α levels decreased on day 14 in both active treatment groups.
What This Means for Canadian Patients
For Canadian patients with chronic leg wounds undergoing hyperbaric oxygen therapy, supplementing with R-(+)-lipoic acid may offer superior healing outcomes compared to standard lipoic acid. This could potentially lead to faster wound closure and reduced inflammation, improving their overall quality of life.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's relatively short duration and specific patient population may limit the generalizability of these findings.